RT-PCR Test Reagent Kit

Introducing our high-quality RT-PCR test reagent, designed specifically for professionals in the medical and scientific fields. This reagent is a crucial tool in accurately detecting and analyzing RNA from various samples. With its advanced formulation, it ensures precise and reliable results in a timely manner. Our RT-PCR test reagent is compatible with a wide range of PCR instruments, making it versatile and adaptable to different laboratory setups. It is manufactured under stringent quality control measures to guarantee consistency and performance. Trust in our RT-PCR test reagent to deliver exceptional sensitivity and specificity, aiding professionals in their research and diagnostic endeavors.

View:

 

RT-PCR nucleic acid detection reagent kit

Brand: Uni-medica

Packaging: expart standard

Supply Ability: 100 000 000 tests/month

This Covid-19 Pcr Diagnostic Reagent kit utilizes a real-time fluorescent PCR detection technology and adopts a pair of specific primers shared by 96-type human papillomavirus (HPV) and a specific fluorescent probe to realize qualitative detection...

Contact Now

Home > Products > Others > RT-PCR Test Reagent Kit

China RT-PCR Test Reagent Kit Suppliers

The RT-PCR Test Reagent Kit is a real-time, RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in oropharyngeal and nasopharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider. This test is also for use with anterior nasal swab specimens that are collected using the COVID-19 Test Collection Kit when used consistent with its authorization.
Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in the upper respiratory specimens during the acute phase of infection.
Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status.
Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations,patient history,and epidemiological information.